By Bruce Sylvester – Even with good clinical management of type 2 diabetes, the risk of premature death increases significantly with the onset of kidney disease, researchers reported… read more.
Researchers have found that macrophages that play a key role in the immune response – also help to both produce and eliminate the body’s red blood cells (RBCs)…. read more.
by Eoghan McNeill – Orlando, Florida – When clinicians observe incidental kidney masses, about 78% of the time they are surgically removed – but a new study suggests… read more.
Directing short bursts of radio waves at nerves surrounding the kidneys lowered blood pressure for at least six months and up to one year among patients with hypertension… read more.
In association with A.Menarini Pharmaceuticals Ireland Ltd – Beta-blockers are one of the most valuable classes of drugs in the therapeutic armamentarium. They have an established place in… read more.
FDA Highlights by Bruce Sylvester – According to a study published online on Nov. 20, 2012 in Arthritis and Rheumatism, rituximab appears to benefit patients with antiphospholipid antibodies… read more.
While living well with type 2 diabetes is possible, when kidney disease emerges the risk of premature death increases significantly,
Women with hypertensive disorders in pregnancy are at higher risk of chronic kidney disease and end-stage renal disease compared with women without the disorders, according to a study… read more.
Cranberry juice is unlikely to prevent bladder and kidney infections, according to an updated systematic review published in The Cochrane Library.
Encouraging safety and efficacy data on novel and emerging therapies presented at the 54th Annual Meeting of the American Society of Haematology (ASH) signal an important step forward… read more.
Proof-of-concept animal study selected as one of the best presentations at 54th American Society of Hematology Annual Meeting and Exposition.
by Marybeth Burke – The investigational drug BMS-936558 caused tumour shrinkage in up to a quarter of patients with advanced melanoma, kidney and NSCLC cancers,
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
